CXCL1 and Alzheimer disease: Notably, we observed a significant increase in plasma Groα and MIP-1α levels in rhApoJ-treated APP23 mice when compared to saline-treated APP23 mice, molecules previously proposed to enhance monocyte migration to the brain in an AD context [56, 57].